Episealer® knee implant
-
Regulatory
Episurf Medical reaches important regulatory milestone in India
December 14, 2022 – Episurf Medical (Nasdaq: EPIS B) today announces that the Indian authorities have, through their Directorate General…
Read More » -
Hospitals
Episurf Medical submits IDE application to the US FDA for the Episealer® knee implant
JUN 28, 2018 Episurf Medical (NASDAQ: EPIS B) today announces that the company has reached an important milestone on its…
Read More »